EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series

Hyeon Gyu Kang, Jiwon Koh, Tae Min Kim, Doo Hee Han, Tae-Bin Won, Dong-Wan Kim, Dong-Young Kim, Bhumsuk Keam

Cancer Research and Treatment · 2024

DOI: 10.4143/crt.2023.1308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2024. Verfasst von Hyeon Gyu Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: DNA Helicases, SMARCB1 Protein, Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SMARCB1 or SMARCA4-deficient sinonasal carcinoma or thoracic undifferentiated tumor has aggressive nature with a poor prognosis. Patients with this disease were diagnosed by immunohistochemistry or next-generation sequencing. Those who were able to receive a surgery tended to be cured, while the others treated with chemotherapy, radiation therapy, or immune checkpoint inhibitor were often insensitive to these therapies. However, one having CD274 (PD-L1) amplification showed the response to immune checkpoint inhibitor and a good prognosis. We believed that this report could provide promising information for determining the optimal treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA HelicasesSMARCB1 ProteinTranscription FactorsAdultAgedFemaleHumansMaleMiddle AgedBiomarkers, TumorNuclear ProteinsPrognosisRetrospective StudiesThoracic Neoplasms

Stichwörter der Autor:innen

SMARCA4SMARCB1Undifferentiated tumor

Substanzen

Biomarkers, TumorDNA HelicasesNuclear ProteinsSMARCA4 protein, humanSMARCB1 ProteinSMARCB1 protein, humanTranscription Factors

Autor:innen und Institutionen

  • Seoul National University College of Medicine, Seoul, Korea.
  • Department of Pathology, Seoul National University Hospital, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Department of Otorhinolaryngology, Seoul National University Hospital, Seoul, Korea.

Zitieren

APA

Kang, H. G., Koh, J., Kim, T. M., Han, D. H., Won, T. B., Kim, D. W., Kim, D. Y., & Keam, B. (2024). Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series. Cancer Research and Treatment. https://doi.org/10.4143/crt.2023.1308

Vancouver

Kang HG, Koh J, Kim TM, Han DH, Won TB, Kim DW, et al. Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series. Cancer Research and Treatment. 2024. doi:10.4143/crt.2023.1308

BibTeX
@article{Kang2024,
  author = {Kang, Hyeon Gyu and Koh, Jiwon and Kim, Tae Min and Han, Doo Hee and Won, Tae-Bin and Kim, Dong-Wan and Kim, Dong-Young and Keam, Bhumsuk},
  title = {Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series},
  journal = {Cancer Research and Treatment},
  year = {2024},
  doi = {10.4143/crt.2023.1308}
}
Kostenlos starten →